In Situ Upregulating Heat Shock Protein 70 via Gastric Nano-Heaters for the Interference of Helicobacter pylori Infection

ACS Nano. 2022 Sep 27;16(9):14043-14054. doi: 10.1021/acsnano.2c03911. Epub 2022 Aug 22.

Abstract

Taking inspiration from the mechanism of Helicobacter pylori infection can lead to innovative antibacterial ways to fight antibiotics resistance. Herein, a gastric nano-heater iron-cobalt alloy shielded with graphitic shells (FeCo@G) is developed to interfere with H. pylori infection under an alternating magnetic field. FeCo@G shows a high and stable specific loss power (SLP = 534.1 W g-1) in the acidic environment and provides efficient magnetothermal stimulation in the stomach. Such stimulation upregulates the cytoprotective heat shock protein 70 (HSP70) in gastric epithelial cells, which antagonizes the infection of H. pylori. This finding is further supported by the transcriptomic analysis verifying the upregulation of HSP70 in the stomach. Moreover, the nano-heater shows a high inhibition rate of H. pylori in vivo with good biocompatibility; 95% of FeCo@G is excreted from the mouse's gastrointestinal tract within 12 h. In summary, FeCo@G allows magnetothermal therapy to be used in harsh gastric environments, providing an approach for the therapy against H. pylori.

Keywords: Helicobacter pylori infection; antibacterial therapy; gastric nano-heaters; magnetothermal stimulation; protein regulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alloys / metabolism
  • Alloys / pharmacology
  • Animals
  • Anti-Bacterial Agents / metabolism
  • Cobalt / metabolism
  • Cobalt / pharmacology
  • Gastric Mucosa / metabolism
  • Gastric Mucosa / microbiology
  • HSP70 Heat-Shock Proteins / metabolism
  • Helicobacter Infections* / metabolism
  • Helicobacter pylori* / metabolism
  • Iron / metabolism
  • Mice
  • Stomach

Substances

  • Alloys
  • Anti-Bacterial Agents
  • HSP70 Heat-Shock Proteins
  • Cobalt
  • Iron